Trials / Completed
CompletedNCT02118792
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 764 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AN2728 Topical Ointment, 2% | |
| DRUG | Matching vehicle control |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-04-21
- Last updated
- 2017-03-06
- Results posted
- 2017-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02118792. Inclusion in this directory is not an endorsement.